You are here: Home / Archives for From the Firm

Child Custody Tracking Software and Custody X Change

April 4, 2012 By Leave a Comment
Daniel's Headshot

**UPDATE 04/06/2012: Ben Coltrin, the Developer of Custody X Change, contacted me by email to ask questions about this review and improve his product.  Its great to hear from a legal software developer who's interested in improving the product even after its enjoyed some success.  I'll be writing a further review of this product in the coming weeks.** As clients prepare to deal with a child custody issue we often advise them to keep a journal of their interactions with the other parent and the child.  Its often helpful to have a record of possession and the typical conflicts that … [Read more...]

Filed Under: Family Law, From the Firm Tagged With: , , , , , , , , , , , , , ,

The New “Loser Pays”

February 14, 2012 By Leave a Comment
jeffTH

A lot of my friends have asked me about the new “loser pays” law and how I expect it to affect litigation in Texas.  For years, Texas and most other states followed the so-called, “American Rule” whereby litigants pay their own attorneys’ fees.  There were exceptions, such as certain statutory provisions that allowed recovery of attorneys fees in breach of contract, declaratory judgments, and other types of lawsuits.  The new law is a departure from our historical approach, and represents a Texas version of the “English Rule,” allowing the prevailing party to recoup … [Read more...]

Filed Under: Bar Related, From the Firm Tagged With: , , , , , , , , , , , , , , ,

The Risks of Using Generic Drugs

November 14, 2011 By Leave a Comment
SarahTH

by Sarah Taylor, SpringerLyle ••• In June of 2011, the United States Supreme Court decided an important issue regarding the warning labels on prescription drugs in Pliva, Inc. et al v. Mensing.  Mensing was a prescription drug failure-to-warn-case.  It dealt with prescription drug companies’ failure to put accurate warnings on their drug labels, leading to patients taking dangerous drugs that they otherwise would not have taken. In Mensing, the Court held that name-brand manufacturers of prescription drugs have an obligation, both under the federal regulations and under state … [Read more...]

Filed Under: From the Firm, Health, Medical Cases, Pharmaceutical Cases Tagged With: , , , , , , , , , , , , , , , , ,

Cancer Risk linked to Diabetes Treatment

November 14, 2011 By Leave a Comment
frankTH

By Frank Lyle “Actos” is the brand name for a drug (pioglitazone) used to treat adult onset, Type-II diabetes. In June of 2011, The Food and Drug Administration (FDA) informed the public that this drug may increase the risk of bladder cancer. The FDA required new warnings to be placed on the medication’s label sold under the names Actos, Actoplus Met and Duetact. The drug has already been pulled off the market in France and Germany. It has been estimated that more than 2 million patients filled prescriptions for the drug between January 2010 and October 2010. Our attorneys at … [Read more...]

Filed Under: From the Firm, Medical Cases, Pharmaceutical Cases Tagged With: , , , , , , , , , , , , , , , ,

New Rules Require Lawyers to be Nice

September 16, 2011 By Leave a Comment
jeffTH

by Jeff Springer, SpringerLyle ••• Texas adopted the “Texas Lawyers’ Creed” several years ago in response to the rising incivility among opposing trial lawyers. Now other states are apparently following suit. The Florida Supreme Court issued an order (PDF) on Monday adopting a civility pledge as part of the oath, the Legal Profession Blog reports. The new language reads: “To opposing parties and their counsel, I pledge fairness, integrity, and civility, not only in court, but also in all written and oral communications.” South Carolina adopted a similar pledge in 2003, the … [Read more...]

Filed Under: Bar Related, From the Firm Tagged With: , , , , , , , , , , , , , ,